Fools were out and about this week in an investing world jampacked with actions and ideas. Here are three articles you might find useful as you decide how to invest your money.

The Biggest Lesson College Will Teach You
If your taxes are done, it must be time to fill out college financial-aid forms.

Fool editor and writer Dan Caplinger highlighted actions taken by Bank of America (NYSE: BAC), Sallie Mae, Citigroup (NYSE: C), and Discover Financial to show how the student-loan business is becoming concentrated among a smaller number of players. That makes it crucial for students and parents to comparison shop among lenders, Dan wrote.

It's especially important as the cost of a college education keeps rising and as various circumstances make loans a larger part of the student-aid package. "Knowing how your loan works, what interest rate you're going to have to pay, and what the repayment terms are will help you figure out whether you can truly manage your debt after you graduate," Dan advises.

Read the article for a more thorough look at the biggest lesson college will teach you.

Buy These 3 Tech Stocks to Hold Forever
When you think about stocks to buy and hold forever, you probably think of companies such as S&P 500 Dividend Aristocrats Procter & Gamble and McDonald's. Tech stocks such as Google (Nasdaq: GOOG) can have a perpetual-motion feel that might make you automatically exclude them from your list of stocks to own forever.

Fool contributor Anders Bylund thinks that would be a mistake. He named Google one of three tech stocks that "fit [Warren] Buffett's criteria of outstandingosity, ready to form the core of an extremely long-term buy-and-hold portfolio."

He talks about Google's skill in changing along with technology and market trends, citing its forays into video service YouTube, mobile-computing platform Android, and green-energy initiatives.

See the article to read more about Google and to find out why Intuitive Surgical (Nasdaq: ISRG) and IBM (NYSE: IBM) also make Anders' list of three tech stocks to hold forever.

Johnson & Johnson Parties Like It's 1982
Nearly 30 years ago, Johnson & Johnson (NYSE: JNJ) took the bold steps necessary to recover from the Tylenol-poisoning incidents. But what about now?

Hit with repeated recalls, Johnson & Johnson has reacted and is "clearly trying to clean up any and every mistake it's made over the last few years," wrote Fool contributor Brian Orelli. The recalls cost the company $900 million in lost sales last year, Brian wrote.

Check out the article, and then use the comments section on that page to let your fellow Fools know whether now's the time to buy or sell JNJ shares, and to weigh in on how much celebrating competitors such as Merck and Medtronic (NYSE: MDT) should be doing.

See a stock in this story you'd like to follow? Add it to My Watchlist, which will find all of our Foolish analysis on it.

Fool online editor Kris Eddy owns no shares of any stocks mentioned in this article. Discover Financial, Google, and Johnson & Johnson are Motley Fool Inside Value selections. Google and Intuitive Surgical are Motley Fool Rule Breakers recommendations. Johnson & Johnson and Procter & Gamble are Motley Fool Income Investor picks. Motley Fool Options has recommended a diagonal call position on Johnson & Johnson. The Fool owns shares of Bank of America, Google, IBM, Johnson & Johnson, and Medtronic; and through a separate account in its Rising Stars portfolios, the Fool has a short position on Bank of America. Motley Fool Alpha owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.